FDA inspection uncovers cherry-colored antibiotic residue on equipment at Teva's New Jersey site
An FDA inspection report on Teva’s manufacturing site in New Jersey has revealed issues with both equipment cleaning and quality.
The three-page report, which …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
